1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. GERON CORP.
Geron Corp. XNAS: GERN

Geron Corp. Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...

Read More
1.40 -0.03 (-2.10%)
70.95% Fall from 52W High
3.4M
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
15.5 / 100
Momentum Score
Technically Neutral
44.4 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
4
1Yr Price target upside is 159%
8 analysts

11

S

12

W

2

O

1

T

SWOT Analysis

Geron Corp. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..